EP Patent

EP1296670A1 — Therapeutic combinations of fatty acids

Assigned to Amarin Neuroscience Ltd · Expires 2003-04-02 · 23y expired

What this patent protects

Eicosapentaenoic acid or any appropriate derivative (EPA) is disclosed in combination with arachidonic acid (AA) or an AA precursor, selected from DGLA and GLA, to give a pharmaceutical formulation.

USPTO Abstract

Eicosapentaenoic acid or any appropriate derivative (EPA) is disclosed in combination with arachidonic acid (AA) or an AA precursor, selected from DGLA and GLA, to give a pharmaceutical formulation.

Drugs covered by this patent

Patent Metadata

Patent number
EP1296670A1
Jurisdiction
EP
Classification
—
Expires
2003-04-02
Drug substance claim
No
Drug product claim
No
Assignee
Amarin Neuroscience Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.